⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MIST News
Milestone Pharmaceuticals Inc. Common Shares
Form 8-K
sec.gov
MIST
Milestone Pharmaceuticals Announces Clinical Data Presentations at Upcoming Cardiology Conferences
globenewswire.com
MIST
Milestone Pharmaceuticals Announces First European Study Participant Enrolled in ReVeRA-301 Phase 3 Clinical Trial
globenewswire.com
MIST
Magnetic Particle Inspection Services Market - Global Forecast 2026-2032 | AI Adoption and Asset Integrity Demand Propel 11.52% CAGR, Creating a USD 3.30 Billion Market by 2032
globenewswire.com
MIST
Testing, Inspection, and Certification (TIC) Market - Global Forecast to 2036: USD 269.6 Billion in 2026 to USD 414.5 Billion by 2036, Profiling SGS, Bureau Veritas, Intertek & 17 Others
globenewswire.com
MIST
Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR
globenewswire.com
MIST
Non-Destructive Testing for Nuclear Industry Market Poised for Growth Through 2033, Driven by Safety Mandates, Aging Reactor Inspections and New Nuclear Investments
globenewswire.com
BA
MIST
Form 8-K
sec.gov
MIST
Milestone Pharmaceuticals Announces NMPA Approval of Etripamil Nasal Spray for PSVT in China, Marking First Regulatory Approval of Etripamil Outside of the United States
globenewswire.com
MIST
Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
globenewswire.com
MIST